By following key strategies, companies can reduce the risk and increase the benefits of outsourcing analytical development and testing
Amy St. Charles
Advertisement
Amy St. Charles is a senior scientist in QC/Stability/Compliance in the Analytical Research and Development of Pfizer Global Biologics
Articles by Amy St. Charles
Advertisement
Latest Updated Articles
Use of Contract Analytical Laboratories: A Pfizer Global Biologics PerspectivePublished: July 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
